![]() |
| Osteosarcoma, Bone Cancer Cell Cancer that starts in the bones, rather than cancer that has spread to the bone, predominantly affects children and young adults Image Credit: National Cancer Institute |
A new drug that works against the main types of primary bone cancer has been developed by researchers at the University of East Anglia and University of Sheffield.
Cancer that starts in the bones, rather than cancer that has spread to bone, predominantly affects children and young adults.
Current treatment is brutal, with outdated chemotherapy cocktails and limb amputation leading to life-long disabilities.
Even after these grueling treatments, the five-year survival rate is still poor at just 42 per cent – largely because of how rapidly bone cancer spreads to the lungs. These rates haven’t changed in nearly half a century.
But a new study published in the Journal of Bone Oncology shows how a new drug called ‘CADD522’ blocks a gene associated with driving the cancer’s spread, in mice implanted with human bone cancer.


.jpg)


.jpg)
.jpg)


